Stock MABVAX THERAPEUTICS HOLDINGS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Mabvax Therapeutics Holdings Inc Nasdaq

Equities

US87959M2089

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Mabvax Therapeutics Holdings Inc
2020 MabVax Therapeutics Holdings, Inc. Went Out of Business CI
2020 Second Amended Liquidation Plan & Disclosure Statment Approved for MabVax Therapeutics Holdings, Inc. CI

Business Summary

MabVax Therapeutics Holdings, Inc. is a clinical-stage biotechnology company with a fully human antibody discovery platform. The Company is focused on the translation into clinical development of products to address the medical needs in the treatment of cancer and pancreatitis. The Company discovered a pipeline of human monoclonal antibody product candidates based on the immune responses generated by patients. The Company's product pipeline includes ImmunoPET Imaging (MVT-2163) and Radioimmunotherapy (MVT-1075). MVT-2163 is an imaging agent for pancreatic cancer. MVT-1075 is a radioimmunotherapy for pancreatic cancer.

Managers

Managers TitleAgeSince
John David Hansen CEO
 Chief Executive Officer 72 -
Philip O. Livingston CTO
 Chief Tech/Sci/R&D Officer 81 14-07-07
Paul W. Maffuid CTO
 Chief Tech/Sci/R&D Officer 68 14-07-07
Wolfgang W. Scholz PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Philip O. Livingston CTO
 Chief Tech/Sci/R&D Officer 81 14-07-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 33,333 0 0 92.02 %
Stock B 0 44,104 0 0
Stock C 1 9,429,582 8,677,104 ( 92.02 %) 0

Company contact information

MabVax Therapeutics Holdings, Inc.

559 Evans Mountain Road

72031, Clinton

+858-259-9405

address Mabvax Therapeutics Holdings Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.97% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.81% 96.29B
ARGENX SE Stock argenx SE
+1.48% 22.18B
BIONTECH SE Stock BioNTech SE
-16.37% 21.2B
GENMAB A/S Stock Genmab A/S
-9.95% 18.31B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.74% 17.38B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.06% 16.36B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.24% 13.97B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+32.72% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. MBVXQ Stock
  4. Stock
  5. Company Mabvax Therapeutics Holdings Inc